DIFLUPREDNATE
Generic: DIFLUPREDNATE
Caplin Steriles LimitedManufacturer
OPHTHALMICRoute
DIFLUPREDNATEActive Substance
2024-12-13Original Approval
DIFLUPREDNATE is FDA application ANDA219441, sponsored by CAPLIN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-07-14
Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies LimiteLack of Assurance of Sterility: customer complaint for defective container where breakage of the pro
Class II2022-08-02
Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., IndLack of Assurance of Sterility: Complaints received of defective container closure.
Class II2022-08-22
Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured by Cipla Ltd., India, Manufactured for: CipLack of Assurance of Sterility: customer complaint for defective container where breakage of the pro
Top Reported Reactions
1
DRUG INEFFECTIVE
76 reports
2
OFF LABEL USE
59 reports
3
EYE PAIN
51 reports
4
EYE IRRITATION
36 reports
5
DIARRHOEA
32 reports
6
FATIGUE
32 reports
7
HEADACHE
32 reports
8
DECREASED APPETITE
28 reports
9
VISION BLURRED
28 reports
10
NAUSEA
26 reports